Quest Diagnostics DGX
NYSE DGX
$245.39 -2.06 (-0.83%)
As of: Sep 18, 2026 · 10:06 AM EDT

Quest Diagnostics (DGX) Cash & Equivalents Growth (3y) (2012 - 2026)

Analysis

Quest Diagnostics (DGX) Cash & Equivalents Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Natera 49.39 Bn 48.29 Bn 486.15 Mn 42.38%
2 Quest Diagnostics 27.49 Bn 26.86 Bn 1.03 Bn 70.63%
3 Labcorp Holdings 26.51 Bn 26.37 Bn 1.11 Bn -58.12%
4 Guardant Health 23.17 Bn 22.12 Bn 219.03 Mn 57.20%
5 Tempus AI 12.59 Bn 11.77 Bn 274.25 Mn 43.65%
6 Caris Life Sciences 8.01 Bn 7.22 Bn 182.38 Mn -
7 Sotera Health 5.53 Bn 5.17 Bn 177.96 Mn 10.74%
8 BillionToOne 4.80 Bn 4.25 Bn 77.11 Mn -
9 Adaptive Biotechnologies 4.40 Bn 4.05 Bn 51.39 Mn 15.85%
10 iRhythm Holdings 3.68 Bn 3.08 Bn 163.21 Mn 58.82%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 70.63%
Mar 31, 2026 30.95%
Dec 31, 2025 10.06%
Sep 30, 2025 -14.86%
Jun 30, 2025 -26.09%
Mar 31, 2025 -35.85%
Dec 31, 2024 -14.29%
Sep 30, 2024 -8.18%
Jun 30, 2024 -21.49%
Mar 31, 2024 -27.23%
Dec 31, 2023 -16.01%
Sep 30, 2023 -55.34%
Jun 30, 2023 -49.66%
Mar 31, 2023 -20.02%
Dec 31, 2022 -35.83%
Sep 30, 2022 17.27%
Jun 30, 2022 42.50%
Mar 31, 2022 15.34%
Dec 31, 2021 86.23%
Sep 30, 2021 55.40%